• 1. Mechanisms of asymmetric induction in catalytic hydrogenation, hydrosilylation and cross-coupling on metal complexes
  Valerii A. Pavlov Russ. Chem. Rev. 2002 71 33

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylpropanes

Research Brief on Propanedioic acid,2-ethyl-2-phenyl- (CAS: 1636-25-5): Recent Advances and Applications

Propanedioic acid,2-ethyl-2-phenyl- (CAS: 1636-25-5), a derivative of malonic acid, has garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief aims to provide an overview of the latest advancements related to this compound, focusing on its synthesis, biological activity, and potential applications in drug development.

Recent studies have explored the role of Propanedioic acid,2-ethyl-2-phenyl- as a key intermediate in the synthesis of bioactive molecules. Its ethyl and phenyl substituents contribute to its stability and reactivity, making it a versatile building block for the development of novel pharmaceuticals. Researchers have utilized this compound in the synthesis of inhibitors targeting enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX), which are implicated in inflammatory diseases.

In a 2023 study published in the *Journal of Medicinal Chemistry*, Propanedioic acid,2-ethyl-2-phenyl- was employed as a precursor for the development of a new class of non-steroidal anti-inflammatory drugs (NSAIDs). The study demonstrated that derivatives of this compound exhibited potent anti-inflammatory activity with reduced gastrointestinal side effects compared to traditional NSAIDs. These findings highlight its potential as a safer alternative for treating chronic inflammatory conditions.

Another area of interest is the compound's role in cancer research. A recent preprint on *bioRxiv* reported that Propanedioic acid,2-ethyl-2-phenyl- derivatives could modulate the activity of histone deacetylases (HDACs), enzymes involved in epigenetic regulation. The study found that these derivatives induced apoptosis in cancer cell lines, suggesting their potential as anticancer agents. Further in vivo studies are underway to validate these findings.

From a synthetic chemistry perspective, advancements in green chemistry have enabled more efficient and sustainable methods for producing Propanedioic acid,2-ethyl-2-phenyl-. A 2022 paper in *Green Chemistry* described a solvent-free catalytic process that significantly reduced waste and improved yield. This innovation aligns with the growing demand for environmentally friendly synthetic routes in pharmaceutical manufacturing.

In conclusion, Propanedioic acid,2-ethyl-2-phenyl- (CAS: 1636-25-5) continues to be a compound of significant interest in chemical biology and pharmaceutical research. Its applications span from anti-inflammatory drug development to potential anticancer therapies, supported by recent advancements in synthesis and biological evaluation. Future research should focus on further elucidating its mechanism of action and exploring its therapeutic potential in clinical settings.

• 3508-94-9(3-Methyl-2-phenylbutanoic Acid)
• 635-51-8(2-phenylbutanedioic acid)
• 4036-30-0((S)-(+)-Phenylsuccinic acid)
• 5465-28-1(2-phenyl-2-ethyl butyric Acid)
• 1135-67-7(1-Phenylcyclohexanecarboxylic acid)
• 77-55-4(1-phenylcyclopentane-1-carboxylic acid)
• 46292-93-7((R)-Phenylsuccinic Acid)
• 37828-19-6(1-phenylcyclobutane-1-carboxylic acid)
• 6120-95-2(1-phenylcyclopropane-1-carboxylic acid)
• 90-27-7(2-Phenylbutyric acid)